Thanks for clarifying. I added some question marks to my...

First 7 Last

Share
Profile

Follow
JiggyJigs

1,440 Posts.

121

08/12/16

22:19

Post #: 21213179
Share

Originally posted by jake0002 ↑

Goodaye,
It would be my understanding that the shares are allocated in the following manner:
1. s/h are allocated their shares based on their allocation of Rights. so if you have 14 shares you get the Right to acquire 1 new share. That's certain.

2. any Rights not taken up are held within the Top-Up Facility.
The Top-up facility is a Facility provided to s/h, who can subscribe for a portion of those shares not taken up by s/h.
It is a facility for shareholders - not Underwriters.
Directors will participate on the same terms as ordinary s/h.
They will NOT get any benefit we ordinary don't get.
if any directors have zero shares, then they cannot participate at all.
so they will only get their firm allocation of shares like us, and they may/may not subscribe for shares in Top-up Facility, but will not get any priority over us.

When the shares under the Top-up facility are allocated, the shares will be allocated on a pro-rata basis, firstly to shareholders (which may include shareholdings of directors).
IF there were any shares left in Top-Up facility after the allocation to s/h, then it is those shares which would be taken up by Underwriters.

given what we have been told, the Underwriters and Sub-Underwriters will not have to take-up any shares.

from STX:
"Eligible Shareholders will be offered the opportunity to apply for shares in excess of their
entitlement (at the same price as their entitlement, of $0.07 per share) under a ‘Top‐Up
Facility’ comprising any shortfall in acceptances for the Rights Issue (Top‐Up Facility). The
Top‐Up Facility will be provided (to Eligible Shareholders (my words))in priority (ahead of (my words)) to the Underwriter and the sub‐underwriters."

poorly worded by STX, but that is pretty much always how these R/I works.
any doubts suggest someone rings STX.
all just IMHO

cheers

Expand

Thanks for clarifying.

I added some question marks to my comments...largely because it didn't pass the sniff test for me, so was half questioning the outcome portrayed in my post.

Anyways, onwards and upwards...let's see some gas already.

STX Price at posting: 7.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

There are more pages in this discussion • 1 more message in this thread...

First 7 Last

Add STX (ASX) to my watchlist

(20min delay)
Last 22.5¢		Change 0.005(2.27%)		Mkt cap ! $643.6M

Open	High	Low	Value	Volume
22.5¢	23.0¢	22.0¢	$2.095M	9.322M

Buyers (Bids)

No.	Vol.	Price($)
37	1543383	22.0¢

Sellers (Offers)

Price($)	Vol.	No.
22.5¢	613863	5

View Market Depth

No.	Vol.	Price($)
35	1420258	0.220
25	2507908	0.215
31	3138998	0.210
30	905703	0.205
64	3874096	0.200

Price($)	Vol.	No.
0.225	541242	3
0.230	778336	21
0.235	1597043	18
0.240	488761	11
0.245	400000	2

Last trade - 16.10pm 09/07/2024 (20 minute delay)

STX (ASX) Chart

Thanks for clarifying. I added some question marks to my...

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for clarifying. I added some question marks to my...

Top Stories

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News